Actions
View Related Publications
| |
S. 2113
(is) - To empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health.
Download Files
|
Formats
| Text (46 KB) | PDF (187 KB) | XML (61 KB) |
|
Descriptive Metadata
| MODS |
|
Authenticity Metadata
| PREMIS |
|
All Format & Metadata Files
| ZIP |
Metadata
Category | Bills and Statutes |
Collection | Congressional Bills |
SuDoc Class Number | Y 1.6: Y 1.4/1: |
Congress Number | 112th
Congress
|
Congress Session | 2nd Session
|
Last Action Date Listed | February 15, 2012 |
Action | Mrs. Hagan introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions |
Bill Number | S. 2113 |
Bill Version  | Introduced in Senate (IS)
|
Full Title | To empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health. |
Sponsors | Kay R. Hagan
(NC) |
Committees | Committee on Health, Education, Labor, and Pensions (Standing) |
Public and Private Law References |
Public Law 111-353 |
United States Code References | 18 U.S.C. 202 21 U.S.C. 301, 355, 356, 360bb, 371, 379d-1, 391, 393
and
399c |
|